Hikma Pharma get US FDA nod for higher dosage of naloxone nasal spray to treat opioid overdose Read more
Glenmark Pharma and Menarini enter into exclusive licensing agreement for commercialising Ryaltris for European markets Read more
Glenmark Pharmaceuticals and Hikma enter into partnership for commercialising RyaltrisT in the US Read more